Brand change: “Blue turns red”

Abiomed is now Johnson & Johnson MedTech.

Abiomed has been part of Johnson & Johnson since the end of 2022. Within the world’s largest MedTech company, Abiomed sits in the Heart Recovery business.

Since the end of 2024, we have supported the transition and redesign of the brand presence at every level: from the website and employer communication to sponsorship activities in football, cycling and volleyball. This also includes communication in physical spaces – inside and around the company and through out-of-home advertising at its Aachen location.

With the campaign “Blue turns red”, we create a powerful signal for target audiences and the public, quickly and firmly establishing the new brand image. Brand change translated into distinctive brand communication.